Audited Unaudited
Financial Year Ended 31 December 2015 2016 2017 2018 2019
No. of Months 12 12 12 12 3
  RM'000 RM'000 RM'000 RM'000 RM'000
 
Revenue 29,720 47,123 55,917 70,090 12,482
Cost of sales (13,654) (27,624) (33,884) (39,532) (8,413)
Gross profit 16,066 19,499 22,033 30,558 4,069
 
Other income 3,648 7,322 8,157 3,478 1,216
Administration expenses (12,105) (18,915) (20,539) (18,992) (3,954)
Finance costs (307) (169) (189) (297) (65)
Net loss on impairment of financial assets - - (87) (55) -
Profit before tax 7,303 7,737 9,375 14,693 1,266
 
Taxation (845) 188 (1,898) (3,090) (322)
Net profit for the financial year/period 6,458 7,924 7,477 11,603 944
 
Other comprehensive income  
Exchange translation differences for foreign operation - (27) (26) (137) -
Total comprehensive income for the financial year / period 6,458 7,897 7,503 11,466 944
 
Net profit for the financial year attributable to:  
Owners of the parent 6,796 8,489 7,865 11,586 858
Non-controlling interests (338) (565) (388) 17 86
6,458 7,924 7,477 11,603 944
 
Total comprehensive income for the year/period attributable to:  
Owners of the parent 6,796 8,462 7,891 11,449 858
Non-controlling interests (338) (565) (388) 17 86
6,458 7,897 7,503 11,466 944
 
Gross EPS (sen) (1) 3.47 2.92 2.72 3.55 0.47
Net EPS (sen) (2) 1.47 1.27 0.97 1.35 0.10
Basic EPS (sen) (3) 1.55 1.28 0.98 1.41 0.10

Notes:-

(1) Calculated based on gross profit divided by the number of Shares in issue.
(2) Calculated based on net profit attributable to owners of the parent divided by the number of Shares in issue.
(3) Calculated based on net profit attributable to owners of the parent divided by the weighted average number of ordinary shares in issue.

* Please read this section in conjunction with Bioalpha Holdings Berhad's Prospectus dated 26 March 2015, Annual Reports and the latest Quarterly Report.